EMA Guideline on Quality of Herbal Medicinal Products Updated
The finale version of the revised EMA guideline on quality of herbal medicinal products/ traditional herbal medicinal products (EMA/CPMP/QWP/2819/00 Rev.2) was published at the end of September 2011. This guideline replaces the previous one from March 2006.
The update of the document has been necessary to incorporate new definitions and responsibilities which have been developed since that time. Moreover, further clarifications and corrections have been added.
The guideline describes the differences between medicinal products containing chemically defined APIs and herbal medicinal products and the resulting requirements and problems. It applies to both human and veterinary medicinal products.
The guideline should be read in conjunction with Annex 7 on herbal products of the EU GMP and the GACP Guideline from 2005.
The following topics are addressed:
- Qualitative and quantitative particulars of APIs for herbal medicinal products
- Description of the preparation of herbal medicinal products
- Control of starting materials
- Intermediate control during the manufacturing process
- Control of the finished product
- Stability tests
At the end of the guideline, you can find a detailed glossary with definitions.
For further information please see the complete "Guideline on quality of herbal medicinal products1/traditional herbal medicinal products".
Dr Günter Brendelberger
CONCEPT HEIDELBERG (a service provider entrusted by the ECA Foundation)
Related GMP News
18.12.2025FDA Form 483: Excel-Based Data Falsification and Duplicate Log Books
18.12.2025Questions and Answers on System Suitability Tests (SST) - Part 1
18.12.2025PharmaLab 2025: Brief Summary of AQCG Track - Save the Date for 2026!
18.12.2025FDA Warning Letter: 1,500 OOS Results with Numerous Inadequate Investigations
17.12.2025FDA Warning Letter Criticises Handling of OOS Results at a Contract Laboratory
17.12.2025FDA Warning: No Recall Conducted Despite Confirmed Benzene Impurity